An interventional study of SJ-RS-WL2015 visual training program software in Intermittent Exotropia, sponsored by Guangzhou Shijing Medical Software. Status unknown at 2 sites in China. Open to participants aged 5 Years to 16 Years. Per ClinicalTrials.gov, last updated 2020-02-10.
Sponsored by Guangzhou Shijing Medical Software · Not applicable, Interventional, and Treatment
Evaluating the effect of SJ-RS-WL2015 visual training program in children with intermittent exotropia after eye surgery, including the improvement of simultaneous perception (I binocular function), fusion (II binocular function), stereopsis (III binocular function).
All the patients are after eye surgery for intermittent exotropia. All the participants with 20/20 or better visual acuity.
Exclusion Criteria:
Item code: SJ-RS-WL2015, a visual training software program, 15 minutes of one section, twice a day, and for 1 year
Other: SJ-RS-WL2015 visual training program software
No special treatment, but observation
It is a software with perceptual learning methods for binocular functions
Also known as: SJ-RS-WL2015 visual training program
Change from Baseline Stereopsis at 12 months
Measured with Synoptophore and Titmus stereo test, respectively
Time frame: 12 months
Change from Baseline Fusion at 12 months
Measured with Worth 4-dot test and Synoptophore, respectively
Time frame: 12 months
Change from Baseline Simultaneous Perception at 12 months
Measured with Bagolini striated lens, Worth 4-dot test, and Synoptophore, respectively
Time frame: 12 months
Change from Baseline Stereopsis at 6 months
Measured with Synoptophore and Titmus stereo test, respectively
Time frame: 6 months
Change from Baseline Fusion at 6 months
Measured with Worth 4-dot test and Synoptophore, respectively
Time frame: 6 months
Change from Baseline Simultaneous Perception at 6 months
Measured with Bagolini striated lens, Worth 4-dot test, and Synoptophore, respectively
Time frame: 6 months
Change from Baseline Stereopsis at 3 months
Measured with Synoptophore and Titmus stereo test, respectively
Time frame: 3 months
Change from Baseline Fusion at 3 months
Measured with Worth 4-dot test and Synoptophore, respectively
Time frame: 3 months
Change from Baseline Simultaneous Perception at 3 months
Measured with Bagolini striated lens, Worth 4-dot test, and Synoptophore, respectively
Time frame: 3 months
Change from Baseline Stereopsis at 2 months
Measured with Synoptophore and Titmus stereo test, respectively
Time frame: 2 months
Change from Baseline Fusion at 2 months
Measured with Worth 4-dot test and Synoptophore, respectively
Time frame: 2 months
Change from Baseline Simultaneous Perception at 2 months
Measured with Bagolini striated lens, Worth 4-dot test, and Synoptophore, respectively
Time frame: 2 months
Change from Baseline Stereopsis at 1 month
Measured with Synoptophore and Titmus stereo test, respectively
Time frame: 1 month
Change from Baseline Fusion at 1 month
Measured with Worth 4-dot test and Synoptophore, respectively
Time frame: 1 month
Change from Baseline Simultaneous Perception at 1 month
Measured with Bagolini striated lens, Worth 4-dot test, and Synoptophore,
Time frame: 1 month
Visual Acuity
by LogMAR Visual Acuity Chart
Time frame: one year
Change from Baseline Deviation Degree at 1 year
by Prism Test
Time frame: 1 year
Change from Baseline Refractive Error at 1 year
by Phoropter
Time frame: 1 year
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Feb 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Guangzhou Shijing Medical Software